Usually, cognitive decline occurs with neuritic and tau pathology, at an intermediate ADNC level, but about a third of people without dementia symptoms at autopsy have AD pathology meeting the criteria for intermediate ADNC [30, 31]. The gene discussed is MAPT; the disease is dementia.